Correlation between prostate specific antigen and prostate volume with disease symptom severity assessed by international prostate symptom score

Background: Benign prostatic hyperplasia (BPH) is clinically defined as prostate adenoma, resulting in bladder outlet obstruction (BOO), which may eventually harm the and even kidneys. For differential diagnosis of male LUTS, uroflowmetry can be used together with non-invasive ultrasound to ascertain flow rate IPP. PSA also an important indicator for diagnosis. International symptoms score (IPSS) assess severity clinical BPH. There a recommendation consider quality life (QoL) index, where QoL ≥3 considered worrisome. Methods: This was retro-prospective study based on secondary primary data collection analysis, pertaining BPH patients who visited site previously well those are coming regular follow-up since 2019. Patient enrolment done at teaching hospital Shree Krishna Hospital affiliated Pramukh Swami Medical College, Bhaikaka University, Karamsad. About 100 presenting lower urinary tract (LUTS) histo-pathologically proven cases were enrolled pursue research objectives. All followed up period 3-months after initiating treatment disease through IPSS upon completion assessed. Results: diagnosis, generally less than 1 μg/l absence confirmed In our study, mean volume reported 43.46±19.35 cc. A positive correlation observed between serum severity. Conclusions: Our evaluated predict correlated it life, PSA. findings line currently available evidences, suggested that QoL, better predictors severity, IPSS.